| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.26 | 3e-15 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.092 | 0.008 |